Почетна › Рак дојке › Luizijana
Kliničke studije za Рак дојке u državi Luizijana
21 studija za Рак дојке traži učesnike na lokacijama u državi Luizijana.
Gradovi u državi Luizijana
Zvanični tekst studije (na engleskom)
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
- Ochsner Medical Center (OMC), New Orleans
Тражи се учесникФаза 1
Узраст од 18 до 55 · Жене · Ажурирано 12. 11. 2026. · NCT07310420S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- LSU Health Baton Rouge-North Clinic, Baton Rouge
- Louisiana Hematology Oncology Associates LLC, Baton Rouge
- Mary Bird Perkins Cancer Center, Baton Rouge
- и још 4
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03418961A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Ochsner Clinic Foundation ( Site 0021), New Orleans
- Louisiana State University Health Sciences Shreveport ( Site 0053), Shreveport
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT06966700Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
- Willis Knighton Cancer Center, Shreveport
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07214532A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Our Lady of the Lake RMC, Baton Rouge
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07174336E-Mindfulness Approaches for Living After Breast Cancer
- Abbeville General Hospital, Abbeville
- University Medical Center New Orleans, New Orleans
- Touro Infirmary, New Orleans
Тражи се учесникФаза 3
Узраст од 18 до 50 · Оба пола · Ажурирано 4. 11. 2026. · NCT06748222Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- LSU Health Baton Rouge-North Clinic, Baton Rouge
- Our Lady of the Lake Physician Group, Baton Rouge
- Our Lady of The Lake, Baton Rouge
- и још 7
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Ochsner LSU Health Monroe Medical Center, Monroe
- LSU Health Sciences Center at Shreveport, Shreveport
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06418204Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Abbeville General Hospital, Abbeville
- Louisiana Hematology Oncology Associates LLC, Baton Rouge
- Mary Bird Perkins Cancer Center - Covington, Covington
- и још 7
Тражи се учесникФаза 3
Узраст од 18 до 60 · Жене · Ажурирано 4. 11. 2026. · NCT05879926A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
- LSU Health Sciences Center, Shreveport
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT07102381A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
- University Medical Center New Orleans, New Orleans
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT07062965A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
- Mary Bird Perkins Cancer Center-Breast & GYN Pavilion ( Site 0042), Baton Rouge
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT06312176A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, Baton Rouge
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 25. 9. 2026. · NCT06103864Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Care Access-Marrero, Marrero
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 2. 9. 2026. · NCT06072612A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
- Ochsner Clinic Foundation, Covington
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 10. 8. 2026. · NCT06926868First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Louisiana State University Health Sciences Center, New Orleans
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 7. 7. 2026. · NCT05768139De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- Louisiana State University Health Science Center, New Orleans
- University Medical Center New Orleans, New Orleans
- Ochsner Medical Center Jefferson, New Orleans
- и још 2
Тражи се учесникФаза 3
Узраст од 50 до 70 · Оба пола · Ажурирано 23. 4. 2026. · NCT04852887SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, New Orleans
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
- Louisiana State University, Shreveport
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 20. 8. 2025. · NCT03053193The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy
- Pennington Biomedical Research Center, Baton Rouge
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Жене · Ажурирано 17. 2. 2025. · NCT06318507CtDNA Based MRD Testing for NAC Monitoring in TNBC
- Louisiana State University, New Orleans
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Жене · Ажурирано 7. 1. 2025. · NCT06230185Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.